Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Government urges universal flu vaccinations

24.08.2010
The flu kills more than 35,000 people in the United States in an average year—and most of those deaths could be prevented with a simple vaccine. After last year’s H1N1 outbreak, the government says everyone over the age of 6 months needs a flu shot this year.
Flu vaccine will soon be available at local pharmacies and doctor’s offices, and government officials are urging everyone over 6 months of age to receive it. This year’s vaccine protects against H1N1 and two other strains of seasonal flu.

The recommendation represents a break from past years, when the government focused on vaccinating people in certain “high-risk” groups and those in contact with people at high risk.

“The message is simple now,” said David Weber, MD, MPH, professor of medicine, pediatrics and epidemiology at the University of North Carolina at Chapel Hill. “If you’re more than 6 months of age, get the vaccine.”

“In an average year, there are more than 200,000 hospitalizations and more than 35,000 deaths from flu. Many of those would be preventable by simply getting the flu shot,” said Weber. “Flu shots are far and away the best way for preventing flu.”

The Advisory Committee on Immunization Practices, a Centers for Disease Control and Prevention (CDC) advisory panel that set the recommendation for universal vaccination cited last year’s H1N1 outbreak—which affected many young, healthy people not traditionally considered to be at high risk for complications from flu—as part of the reason for the change. In addition, the list of conditions that put a person at high risk has grown so much over the years that many people are unaware of their high-risk status. Universal vaccination is expected to better protect individuals and the population as a whole.

People should receive the vaccine every year as soon as it becomes available, said Weber. “It’s important every year. This year it may be more important because anybody who didn’t get H1N1 last year is susceptible to it, and since that was the first year H1N1 was around, many people, if not most people, are susceptible.”

The vaccine is reformulated each year to provide protection against the virus strains that present the greatest public health threat for that year. People who contracted H1N1 last year may have a lower chance of contracting it again this year, but they should still receive the vaccine for protection against seasonal flu.

Adults need only one dose of the vaccine. Children 6 months to 8 years old may need two doses, depending on which vaccines they received last year.

The vaccine will be available at doctor’s offices and at many pharmacies as both a nasal spray and as a shot. The shot is recommended for people younger than 2 or older than 49, and people with a suppressed immune system. The nasal spray is appropriate for most other healthy people.

Les Lang | EurekAlert!
Further information:
http://www.cdc.gov/flu

More articles from Health and Medicine:

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

nachricht Highly precise wiring in the Cerebral Cortex
21.09.2017 | Max-Planck-Institut für Hirnforschung

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Comet or asteroid? Hubble discovers that a unique object is a binary

21.09.2017 | Physics and Astronomy

Cnidarians remotely control bacteria

21.09.2017 | Life Sciences

Monitoring the heart's mitochondria to predict cardiac arrest?

21.09.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>